Infusion Pump News and Research

RSS

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen and Xencor, Inc. announced today that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.

16 Sep 2015

WellSpan Health, CareFusion announce successful implementation of Alaris System in WellSpan hospitals

WellSpan Health and CareFusion, a BD company, today announced the successful implementation of the Alaris System across all four WellSpan hospitals, with WellSpan York Hospital becoming the first hospital ever to simultaneously go-live with new infusion devices and bi-directional interoperability between the infusion device and the electronic health record (EHR).

10 Jun 2015

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.

29 May 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen today announced that it will present data from multiple Kyprolis (carfilzomib) for Injection, BLINCYTO (blinatumomab), oprozomib and Nplate (romiplostim)‎ studies at the 20th Congress of the European Hematology Association taking place in Vienna, June 11 - 14, 2015.

28 May 2015

CME Medical to distribute eZono 4000 for use in multiple clinical settings

CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono 4000.

15 May 2015

New treatment shows promise in easing symptoms of Parkinson's disease

To date, a cure for Parkinson's disease remains elusive for the more than 50,000 Americans diagnosed yearly, despite decades of intensive study. But a newly approved treatment that might help ease the symptoms of Parkinson's has shown remarkable promise.

22 Apr 2015

Study: Levodopa-carbidopa intestinal gel improves quality of life in advanced PD patients

Although levodopa remains the "gold standard" to effectively control motor deficits in the treatment of early stage Parkinson's disease (PD), it loses effectiveness as the disease progresses. After four to six years of treatment with oral medications for Parkinson's disease, about 40% of patients experience lack of muscle control (dyskinesias), end-of-dose wearing off, and fluctuations in "On/Off" states.

27 Feb 2015

Ivenix develops groundbreaking infusion management platform to transform infusion pump market

Ivenix, Inc. today announced that it is developing a groundbreaking infusion management platform designed to transform the infusion pump market by helping to improve patient safety and clinical workflow efficiency.

26 Jun 2014

Dean Kamen named recipient of 2014 MDEA Lifetime Achievement Award

UBM Canon's Medical Design Excellence Awards, the MedTech Industry's Premier Awards Program, has announced Dean Kamen as the recipient of the 2014 MDEA Lifetime Achievement Award.

4 Jun 2014

Smiths Medical gets FDA clearance to market CADD-Solis system with PIB and PCA delivery in the US

Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable, infusion system will help healthcare providers overcome challenges in maintaining effective epidural analgesia during labor and delivery or with post-operative pain management.

2 Jan 2014

CME Medical to highlight effectiveness of nutrition pumps at two key healthcare nutrition events

CME Medical will be promoting its nutrition pumps – the BodyGuard 323 Ambulatory Infusion Pump and the BodyGuard 2CH Twin Channel Infusion Pump and a new range of rucksacks to carry them in, at two key healthcare nutrition events coming soon.

20 Sep 2013

Washington area hospital group launches its own health insurance plan

In other industry news, the growth of jobs in the health care sector could be a double-edged sword and hospitals seek solution to "alarm fatigue."

9 Jul 2013

First Edition: July 8, 2013

Today's early morning highlights from the major news organizations, including news about a new ad campaign against the health law, more reaction to the administration's delay of the employer mandate provision and states efforts to restrict abortions.

8 Jul 2013

Promising approach to reduce risk of hypoglycemia in diabetes shows positive results

People with type 1 diabetes who rely on insulin injections to control their blood sugar levels are at risk for life-threatening hypoglycemic events in which their blood glucose levels drop dangerously low.

25 Jun 2013

Pancreas stem cells can be turned into insulin producing cells

Stem cells in the adult pancreas have been identified that can be turned into insulin producing cells, a finding that means people with type 1 diabetes might one day be able to regenerate their own insulin-producing cells.

15 Nov 2012

FDA approves Codman’s MEDSTREAM Programmable Infusion System

Codman & Shurtleff, Inc. (Codman), the global neurological device company, has received U.S. Food and Drug Administration (FDA) approval through a PMA supplement for its MEDSTREAM Programmable Infusion System, an implantable infusion pump and catheter system used in the treatment of spasticity, a movement disorder often caused by stroke, cerebral palsy, multiple sclerosis or spinal cord injury.

9 Aug 2012

IRadimed receives Novation contract for MRidium MRI Infusion Pump Systems

Novation, the largest health care supply contracting company in the United States, has awarded IRadimed Corporation a three-year single source contract for its MRidium MRI Infusion Pump Systems.

5 Jun 2012

Increasing Use of Smart Pumps to help drive down “Never Events”

Increased focus on providing optimum patient care in the most cost efficient way is fuelling demand for intelligent infusion devices termed “Smart Pumps.” A report from InMedica, a division of IMS Research (recently acquired by IHS Inc. (NYSE:IHS)), on the global market for infusion pumps found that, despite market saturation in the developed countries, demand for advanced technology is being maintained; infusion pump suppliers must offer technically advanced products at competitive prices to maintain market share.

17 May 2012

Positive results from Nile's cenderitide Phase 1 trial on chronic heart failure

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.

29 Mar 2012

FDA clears Hospira's Symbiq 3.13 infusion device

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced today that the company has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Symbiq 3.13 infusion device, the enhanced version of the company's advanced infusion system platform.

9 Mar 2012